journal
https://read.qxmd.com/read/38720105/artificial-intelligence-in-epilepsy-applications-and-pathways-to-the-clinic
#21
REVIEW
Alfredo Lucas, Andrew Revell, Kathryn A Davis
Artificial intelligence (AI) is rapidly transforming health care, and its applications in epilepsy have increased exponentially over the past decade. Integration of AI into epilepsy management promises to revolutionize the diagnosis and treatment of this complex disorder. However, translation of AI into neurology clinical practice has not yet been successful, emphasizing the need to consider progress to date and assess challenges and limitations of AI. In this Review, we provide an overview of AI applications that have been developed in epilepsy using a variety of data modalities: neuroimaging, electroencephalography, electronic health records, medical devices and multimodal data integration...
May 8, 2024: Nature Reviews. Neurology
https://read.qxmd.com/read/38664569/author-correction-the-complex-aetiology-of-cerebral-palsy
#22
Steven J Korzeniewski, Jaime Slaughter, Madeleine Lenski, Peterson Haak, Nigel Paneth
No abstract text is available yet for this article.
April 25, 2024: Nature Reviews. Neurology
https://read.qxmd.com/read/38622282/neuronal-activity-drives-glymphatic-waste-clearance
#23
JOURNAL ARTICLE
Lisa Kiani
No abstract text is available yet for this article.
April 15, 2024: Nature Reviews. Neurology
https://read.qxmd.com/read/38609644/neurofilaments-as-biomarkers-in-neurological-disorders-towards-clinical-application
#24
REVIEW
Michael Khalil, Charlotte E Teunissen, Sylvain Lehmann, Markus Otto, Fredrik Piehl, Tjalf Ziemssen, Stefan Bittner, Maria Pia Sormani, Thomas Gattringer, Samir Abu-Rumeileh, Simon Thebault, Ahmed Abdelhak, Ari Green, Pascal Benkert, Ludwig Kappos, Manuel Comabella, Hayrettin Tumani, Mark S Freedman, Axel Petzold, Kaj Blennow, Henrik Zetterberg, David Leppert, Jens Kuhle
Neurofilament proteins have been validated as specific body fluid biomarkers of neuro-axonal injury. The advent of highly sensitive analytical platforms that enable reliable quantification of neurofilaments in blood samples and simplify longitudinal follow-up has paved the way for the development of neurofilaments as a biomarker in clinical practice. Potential applications include assessment of disease activity, monitoring of treatment responses, and determining prognosis in many acute and chronic neurological disorders as well as their use as an outcome measure in trials of novel therapies...
April 12, 2024: Nature Reviews. Neurology
https://read.qxmd.com/read/38609643/addressing-disparities-in-neurology-by-identifying-gaps-in-hospital-care
#25
Lisa Kiani
No abstract text is available yet for this article.
April 12, 2024: Nature Reviews. Neurology
https://read.qxmd.com/read/38594557/btk-inhibitor-falters-in-multiple-sclerosis-trials
#26
JOURNAL ARTICLE
Heather Wood
No abstract text is available yet for this article.
April 10, 2024: Nature Reviews. Neurology
https://read.qxmd.com/read/38580849/support-for-network-theories-of-schizophrenia
#27
JOURNAL ARTICLE
Martijn P van den Heuvel, Sara L Seoane
No abstract text is available yet for this article.
April 5, 2024: Nature Reviews. Neurology
https://read.qxmd.com/read/38570705/neurostimulation-for-treatment-of-post-stroke-impairments
#28
REVIEW
Jesse Dawson, Azmil H Abdul-Rahim, Teresa J Kimberley
Neurostimulation, the use of electrical stimulation to modulate the activity of the nervous system, is now commonly used for the treatment of chronic pain, movement disorders and epilepsy. Many neurostimulation techniques have now shown promise for the treatment of physical impairments in people with stroke. In 2021, vagus nerve stimulation was approved by the FDA as an adjunct to intensive rehabilitation therapy for the treatment of chronic upper extremity deficits after ischaemic stroke. In 2024, pharyngeal electrical stimulation was conditionally approved by the UK National Institute for Health and Care Excellence for neurogenic dysphagia in people with stroke who have a tracheostomy...
April 3, 2024: Nature Reviews. Neurology
https://read.qxmd.com/read/38570703/approval-of-omaveloxolone-for-friedreich-ataxia
#29
JOURNAL ARTICLE
Sylvia Boesch, Elisabetta Indelicato
No abstract text is available yet for this article.
April 3, 2024: Nature Reviews. Neurology
https://read.qxmd.com/read/38744998/blood-test-for-early-parkinson-disease-diagnosis
#30
COMMENT
Lisa Kiani
No abstract text is available yet for this article.
June 2024: Nature Reviews. Neurology
https://read.qxmd.com/read/38594556/ebv-specific-t-cells-in-multiple-sclerosis
#31
JOURNAL ARTICLE
Heather Wood
No abstract text is available yet for this article.
May 2024: Nature Reviews. Neurology
https://read.qxmd.com/read/38570704/insights-into-epileptogenesis-from-post-traumatic-epilepsy
#32
REVIEW
Matthew Pease, Kunal Gupta, Solomon L Moshé, Daniel J Correa, Aristea S Galanopoulou, David O Okonkwo, Jorge Gonzalez-Martinez, Lori Shutter, Ramon Diaz-Arrastia, James F Castellano
Post-traumatic epilepsy (PTE) accounts for 5% of all epilepsies. The incidence of PTE after traumatic brain injury (TBI) depends on the severity of injury, approaching one in three in groups with the most severe injuries. The repeated seizures that characterize PTE impair neurological recovery and increase the risk of poor outcomes after TBI. Given this high risk of recurrent seizures and the relatively short latency period for their development after injury, PTE serves as a model disease to understand human epileptogenesis and trial novel anti-epileptogenic therapies...
May 2024: Nature Reviews. Neurology
https://read.qxmd.com/read/38575763/diversity-equity-and-inclusion-in-neurology
#33
EDITORIAL
(no author information available yet)
No abstract text is available yet for this article.
April 2024: Nature Reviews. Neurology
https://read.qxmd.com/read/38575762/addressing-disparities-in-neurology-by-building-the-workforce-in-lmics
#34
JOURNAL ARTICLE
Lisa Kiani
No abstract text is available yet for this article.
April 2024: Nature Reviews. Neurology
https://read.qxmd.com/read/38443479/%C3%AE-synuclein-seeds-in-amyotrophic-lateral-sclerosis
#35
COMMENT
Ian Fyfe
No abstract text is available yet for this article.
April 2024: Nature Reviews. Neurology
https://read.qxmd.com/read/38443478/mitochondrial-dna-marks-multiple-sclerosis
#36
JOURNAL ARTICLE
Ian Fyfe
No abstract text is available yet for this article.
April 2024: Nature Reviews. Neurology
https://read.qxmd.com/read/38443476/metabolic-changes-in-status-epilepticus
#37
COMMENT
Ian Fyfe
No abstract text is available yet for this article.
April 2024: Nature Reviews. Neurology
https://read.qxmd.com/read/38388568/building-an-ethnically-and-racially-diverse-neurology-workforce
#38
REVIEW
Roy H Hamilton
As diversity among patient populations continues to grow, racial and ethnic diversity in the neurology workforce is increasingly essential to the delivery of culturally competent care and for enabling inclusive, generalizable clinical research. Unfortunately, diversity in the workforce is an area in which the field of neurology has historically lagged and faces formidable challenges, including an inadequate number of trainees entering the field, bias experienced by trainees and faculty from minoritized racial and ethnic backgrounds, and 'diversity tax', the disproportionate burden of service work placed on minoritized people in many professions...
April 2024: Nature Reviews. Neurology
https://read.qxmd.com/read/38228908/addressing-disparities-in-the-global-epidemiology-of-stroke
#39
REVIEW
Morgan L Prust, Rachel Forman, Bruce Ovbiagele
Stroke is the second leading cause of death and the third leading cause of disability worldwide. Though the burden of stroke worldwide seems to have declined in the past three decades, much of this effect reflects decreases in high-income countries (HICs). By contrast, the burden of stroke has grown rapidly in low-income and middle-income countries (LMICs), where epidemiological, socioeconomic and demographic shifts have increased the incidence of stroke and other non-communicable diseases. Furthermore, even in HICs, disparities in stroke epidemiology exist along racial, ethnic, socioeconomic and geographical lines...
April 2024: Nature Reviews. Neurology
https://read.qxmd.com/read/38499761/neurological-care-for-lgbt-people
#40
REVIEW
Salvatore Giovanni Volpe, Joya Ahmad, Roshni Abee Patel, Nicole Rosendale
Sexual and gender minority (LGBT+) people face unique health disparities that must be considered by health-care providers to ensure equitable and inclusive care. Although traditionally LGBT+ health has not been integrated into neurology training, sexual orientation and gender identity have direct relevance to neurological health, driven by both systemic and interpersonal factors. In this Review, we summarize the evidence for associations between sexual orientation and gender identity with the prevalence and outcomes of various neurological conditions, including neurodegenerative diseases, epilepsy, stroke and neurodevelopmental disorders, among others...
March 18, 2024: Nature Reviews. Neurology
journal
journal
42294
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.